News
Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Beats Revenue Estimates
Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to a loss of $1.7 per share a year ago. These
Microsoft (MSFT) Q4 Earnings and Revenues Beat Estimates
Microsoft (MSFT) came out with quarterly earnings of $3.65 per share, beating the Zacks Consensus Estimate of $3.35 per share. This compares to earnings of $2.95 per share a year ago. These figures
Sprouts Farmers (SFM) Q2 Earnings and Revenues Surpass Estimates
Sprouts Farmers (SFM) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.94 per share a year ago. These
DexCom (DXCM) Q2 Earnings and Revenues Top Estimates
DexCom (DXCM) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.43 per share a year ago. These figures are
FormFactor (FORM) Q2 Earnings Miss Estimates
FormFactor (FORM) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.35 per share a year ago. These figures
Cognizant (CTSH) Q2 Earnings and Revenues Surpass Estimates
Cognizant (CTSH) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.17 per share a year ago. These figures
Meta Platforms (META) Tops Q2 Earnings and Revenue Estimates
Meta Platforms (META) came out with quarterly earnings of $7.14 per share, beating the Zacks Consensus Estimate of $5.83 per share. This compares to earnings of $5.16 per share a year ago. These
Qualcomm (QCOM) Q3 Earnings Surpass Estimates
Qualcomm (QCOM) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.7 per share. This compares to earnings of $2.33 per share a year ago. These figures
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
Hologic (HOLX) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.06 per share a year ago. These figures
Neurocrine Biosciences (NBIX) Q2 Earnings and Revenues Beat Estimates
Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.63 per share a year ago
Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended May 2025, Neogen (NEOG) reported revenue of $225.46 million, down 4.8% over the same period last year. EPS came in at $0.05, compared to $0.10 in the year-ago quarter.
The
Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
The technology sector is in a constant state of transformation. The rapid adoption of artificial intelligence (AI) and the shift to multi-cloud environments have created immense opportunities
Top Research Reports for Apple, Meta Platforms & ServiceNow
Wednesday, July 30, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc.
Rocketing Volume: 3 Stocks With Big Potential Moves
It seems that trading the S&P 500 index lately has become an afterthought for most investors on Wall Street, especially considering how little volatility there has been recently to compress the
Axalta Coating Systems (AXTA) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Axalta Coating Systems (AXTA) reported revenue of $1.31 billion, down 3.4% over the same period last year. EPS came in at $0.64, compared to $0.57 in the year-ago
Will Arista Networks Stock Keep Soaring as Q2 Earnings Approach?
Arista Networks ANET has joined a wave of tech stocks that are receiving upgrades from analysts thanks to its AI-driven data center innovation and robust revenue growth.
Considering such, there is
Why Lyft’s Stock Volume Just Spiked—Is an EV Partnership Near?
Whenever sentiment changes for a stock, investors can typically spot the shift before the big move happens and a window of opportunity quickly closes. A subtle sign can be found in a stock’s
V.F. Corp Q1 Loss Narrower Than Expected, Sales Beat Expectations
V.F. Corporation VFC reported a narrower-than-expected loss per share in first-quarter fiscal 2026 results, with a sales beat. While earnings improved year over year, revenues dipped. Nevertheless
Newell to Report Q2 Earnings: Does a Surprise Await Investors?
Newell Brands Inc. NWL is expected to register a year-over-year decline in the top and bottom lines when it reports second-quarter 2025 results on Aug. 1, before the opening bell. The Zacks
Altria Q2 Earnings Beat Estimates, FY25 EPS Guidance Narrowed
Altria Group Inc. MO posted second-quarter 2025 results, wherein both top and bottom lines beat the Zacks Consensus Estimate and increased year over year. The company's continued progress toward its
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Humana Inc. HUM reported second-quarter 2025 adjusted earnings of $6.27 per share, which missed the Zacks Consensus Estimate by 0.8%. The bottom line decreased 9.9% year over year.
Adjusted
Global Value: 3 Stocks Under $10 Riding a Weak Dollar
Like many things, diversification isn’t a priority to many investors until it is. In 2025, a weak dollar has many investors looking for better returns from international stocks. The macroeconomic
Teradyne Q2 Earnings Beat Estimates, Revenues Decrease Y/Y
Teradyne TER reported second-quarter 2025 non-GAAP earnings of 57 cents per share, which beat the Zacks Consensus Estimate by 5.56% but plunged 33.7% year over year. The figure came in above the
Strong Cloud Subscription Aids PEGA's Prospects: What's More to Come?
Pegasystems PEGA expects strong traction in its cloud-subscription business to continue, which is increasingly driving overall cloud growth. Key initiatives to sustain this momentum include a 5-year


